We examined the mRNA and protein expression levels of LPAR2 in pan-cancer and the corresponding normal tissues using Oncomine, TIMER, UALCAN, and HPA databases, as well as validated by R software in TCGA and GEO databases. This evidence concerns the gene LPAR2 and cancer.